Avid Bioservices Inc (CDMO)

[biopharm]

$2.9 Billion is the deal Ronin group likely has lined up with Big Pharma for Peregrine assets ....which is Medarex price tag bought by BMS but all know now how Medarex BOD shakeup brought in BODs that did not follow fiduciary duty and only sought one bid!! Goldman Sachs even acknowledge this failure of the new BOD at Medarex ....

....and this $2.9B steal by Bristol Myers Squibb is exactly the scenario playing out here it seems as a BOD shake up is sought to Halt PS Targeting and Halt further validation of the science like with Dr Jedd Wolchok

The game is over

Ronin group is over.....unless they get this in writing and filed with SEC that Halting of PS Targeting is off the table